Pirroxan in the treatment of the neurovegetative component of the depressive syndrome.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004146:Dioxanes / Q000627:therapeutic use*; D004147:Dioxins / Q000627:therapeutic use*; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*
D000928:Antidepressive Agents; D004146:Dioxanes; D004147:Dioxins; D011759:Pyrrolidines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D009638:Norepinephrine; D004837:Epinephrine